Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Effects of a new medication on emotional processing in people experiencing low mood

Trial categories: Brain

Sponsoring organisation: University of Oxford

Low in mood?

Participants needed for an emotional decision making drug study, the RESTAND Study.

We are looking for volunteers aged 18 - 65 who are currently feeling depressed to participate in a study investigating the effects of a new medication on emotional decision making.

If you are NOT taking antidepressant medication, you may be eligible for this study.

Duration

Four appointments (one screening visit, one first dose appointment, and two research visits) - about 13 hours in total.

Who can participate?

Participants who are feeling depressed/low and not taking antidepressant medication or undergoing psychological therapy.

What does the study involve?

The study mainly involves taking medication for 7 days, computer-based psychological tasks, questionnaires and may include one brain imaging scan using functional Magnetic Resonance Imaging (fMRI).

You will be reimbursed for your time and expenses.

For further information in confidence with no obligation to participate, contact us: